ANCC Guidelines and Requested Topics for Abstracts
APHON is an accredited provider of continuing nursing education (CNE) with the American Nurses Credentialing Center (ANCC) and is responsible for developing and evaluating individual educational activities in compliance with current ANCC Accreditation Program criteria. ANCC recently released new criteria which has shifted from a focus on behavioral learning objectives to outcome based education.
A “learning or professional practice gap” is the term used to describe a learner’s deficiencies and educational needs, which if eliminated results in improvements in knowledge, competence and/or performance that can potentially improve health outcomes. Gaps may be defined as the difference between “the way things are” (current state) and “the way they should be” (desired/achievable state).
The following topics are requested for submission to address learning gaps identified by previous conference attendees.
Red Cell Disorders (sickle cell disease and thalassemia) | Platelet disorders (ITP and platelet function defects) | Bleeding disorders (hemophilia and von Willebrand disease) | Thrombosis/Clotting | Vascular Malformations | Aplastic Anemia and Bone Marrow Failure
Solid Tumors | Hematologic Malignancies (leukemia and Lymphoma) | CNS Tumors | Radiation Therapy | Symptom Management | Oncologic Complications/Emergencies
Stem Cell Transplant
Innovative Therapies (unrelated, haploidentical and cord blood transplant) | Post HSCT Complications and Management (GVHD, SOS, Graft Rejection) | Stem Cell Transplant for nonmalignant disorders
General Clinical Practice
Genetics (education/therapy/effect and treatment plans) | Disease Related Biology | Complementary Therapies | Health Therapy Alternatives |Ethical Dilemmas | Radiology/Imaging
Pain Management | Transfusion Therapy | Infection Control/Prophylaxis | Distress Assessment/Management | Mental/Emotional Support | Nutritional Support | Fertility Preservation | Transition to Adult Care | Survivorship | End of Life/Palliative Care
Adolescent/Young Adult (AYA)
Development Considerations | Incorporation of AYA in Pediatric Programs | Program Development
New or Emerging Therapies
Phase 1 and 2 Clinical Trials | Molecular Guided Therapy | Immunotherapy | Targeted Therapy | Car T-Cell Therapy | Gene Therapy
Clinical Pearls and Tips | Diagnostic Dilemmas | Procedure Training and Competency | Prescribing Practices | Professional Practice | Scope of Practice Boundaries | Pharmacology | Opioid Prescribing Challenges | Documentation of Outcomes | Critical Conversations
Evidence-Based Practice | Quality Improvement | Standards for Care | Self-Care/Resiliency | Professional Boundaries | Staffing and Acuity | Legislative Updates
Adult learning principles for Pediatric Chemotherapy/Biotherapy Instructors | Professional Development Topics (professional writing for grants, abstracts or articles) | NP Residency/Fellowship Programs
Healthcare Updates and Policies | Emergency Preparedness | Team Building
Description of current state:
Pediatric Hematology/Oncology Nursing is a continuously evolving field of practice, but many nurses report they are challenged to keep up with new and innovative therapies being used to treat their patients as well as current trends in hematology/oncology and stem cell transplant and other aspects of care.
Description of desired/achievable state:
Pediatric Hematology/Oncology nurses need to have the knowledge, skills and the ability to apply new information learned as they care for their patients, families and themselves.
The desired learning outcomes for the 2019 Annual Conference are the following:
Learning Outcome 1:
The learner will be able to incorporate or identify strategies essential for managing the challenges facing pediatric hematology/oncology nurses and the patients we serve.
Learning Outcome 2:
TThe learner will demonstrate increased knowledge related to the care of children, adolescents and young adults with hematologic or oncologic disorders while implementing self-care strategies.
The measurement of these outcomes will be evidenced by pre and post testing as well as the results of 30, 60 and 90 day surveys.